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Background: Fat-free mass (FFM) depletion has been shown to be a better predictor of mortality than BMI in
chronic obstructive pulmonary disease (COPD) patients. The specific aim of the current study was to assess the
nutritional status of stable COPD patients in relation to fat free mass index profiles.
Methods: We investigated 65 male moderate-to-severe stable COPD patients. A self-reported questionnaire was applied
about general characteristics and smoking history. Nutritional intake was assessed by using a 54–item quantitative food
frequency questionnaire. Weight, height, mid-upper arm circumference (MUAC), waist circumference (WC), handgrip
strength and body composition measurements were taken by a trained dietitian. The data were analyzed with
SPSS 15.0 software.
Results: The mean age of the patients was 62.1 ± 8.9 years. Among all of the patients 13.8% was underweight
(BMI < 21 kg/m2) and 18.5% had a low fat-free mass index (FFMI < 16 kg/m2). The percentages of the patients
who did not meet the daily recommended intakes (RNI) were highest for magnesium (93.8%) and calcium (92.3%). Mean
daily consumptions of milk-yogurt, red meat and fruits were significantly low in the low FFMI group compared to normal
FFMI group (for all; p < 0.05). Patients with normal FFMI had significantly higher weight, height, WC, MUAC, handgrip
strength, fat and fat-free mass than the patients with low FFMI (for all; p < 0.05).
Conclusions: Dieticians should be aware of COPD patients with low FFMI in order to evaluate the nutritional intake and
therefore plan nutritional strategies to improve prognosis of the disease.
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Chronic Obstructive Pulmonary Disease (COPD) is a
preventable disease characterized by persistent airflow
limitation that is usually progressive. It is a leading cause
of morbidity and mortality worldwide and results in an
economic and social burden [1]. COPD should not be
considered as a localized pulmonary disorder but as a
systemic disease. Well-characterized systemic features
are muscle atrophy and weakness and osteoporosis [2].
The nutritional status of patients with COPD has been
considered an important factor that influences the prog-
nosis of the disease [3]. Approximately 20–40% of COPD* Correspondence: htbf@hacettepe.edu.tr
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unless otherwise stated.outpatients have been reported as underweight or mal-
nourished [4]. Body composition is reported to be one of
the main determinants of functional disability of COPD
patients independent of respiratory functions [5]. Weight
loss and depletion of fat-free mass (FFM) may be observed
in stable COPD patients, irrespective of the degree of air-
flow limitation and they are reported to contribute to
morbidity, disability, and handicap [6]. Increased muscle
protein break-down is a key feature in muscle wasting.
This process of cachexia can be considered the result of
interplay of systemic factors, including systemic inflamma-
tion, oxidative stress, and growth factors that may synergize
with local factors leading to protein imbalance [7]. It is im-
portant to recognize that muscle mass may be reduced in
COPD patients despite a normal BMI [8]. Fat-free mass
index (FFMI) has been reported to provide informationThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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has been shown that fat-free mass (FFM) depletion is a bet-
ter predictor of mortality than BMI alone in COPD patients
[9]. A recent study on 564 moderate to severe COPD pa-
tients in the Netherlands showed that disturbances in body
composition were associated with dramatic differences in
macro- and micronutrient intake [11].
Therefore, the specific aims of the current study were
to examine the nutritional status of stable moderate to
severe male COPD patients and to evaluate energy,




A cross-sectional study was conducted to determine the
nutritional status of male COPD patients. The study
population was recruited from COPD patients who visited
the outpatient respiratory clinics of Ankara Ataturk Chest
Diseases and Thoracic Surgery Training and Research Hos-
pital, Turkey. Patients who are over 45 years of age, without
any signs of infection and cognitively intact to answer the
questions were invited to the study. The diagnosis and sta-
ging of COPD was made by pulmonologists according to
American Thoracic Society/European Respiratory Society
(ATS/ERS) and Global Initiative for Chronic Obstructive
Lung Disease (GOLD) guidelines [1,6]. To be included in
the study, patients had to be in a stable condition and not
have reported acute symptoms or therapy modifications in
the 30 days before enrollment. Patients with chronic kidney
failure, diabetes, malignancy, congestive heart failure, myo-
cardial infarction in the last 2 years were excluded from the
study. In total, 65 male COPD patients (33 moderate, 32 se-
vere) were included in the final data analysis of this study.
The study protocol complied with the principles laid
down in the Declaration of Helsinki and was approved
by the Hacettepe University Senate Ethics Committee
(B.30.2. HAC.0.70.00.01/431-1855 2010). Written informed
consent was obtained from all subjects.
Measurements
Characteristics of participants
A self-reported questionnaire was applied to the patients by
face-to-face interview method to collect information about
age, gender, educational level, total monthly family income,
duration since diagnosed with COPD and smoking history.
Nutritional intake and physical activity
Nutritional intake and habitual food consumption was
assessed by an 54–item quantitative food frequency ques-
tionnaire asking for dietary habits in the last 6 months by a
trained dietitian. In order to assist respondents in identify-
ing the actual quantity of the foods, a Turkish food photo-
graph catalogue was used. Reported information wasconverted into a daily intake frequency of each item, which
was in turn converted into the daily intake in grams per
day for each food. The dietary data was analysed using
BeBIS-6.1 (Nutrition Information Systems Software) and
total intake of energy, carbohydrate, protein, fat, fiber, vita-
min A, vitamin E, vitamin C, vitamin B12, calcium, iron,
zinc and magnesium were calculated. Dietary intake was in-
dividually compared with gender- and age group- specific
Turkish recommendations given in the Dietary Guidelines
for Turkey (DGT) [12]. The exact RNI values were used as
strict cutoff values to categorize dietary intake (e.g., <RNI
and ≥RNI). The physical activity levels (PAL) were assessed
by a 24-h physical activity recall by a trained dietitian.
Anthropometric measurements and body composition
Anthropometric assessment consisted of determination of
weight (kg), height (m), mid-upper arm circumference
(MUAC) (cm) and waist circumference (cm). Height was
measured with a clinical stadiometer while the patient was
standing barefoot. Body weight was measured using a cali-
brated scale, with the patient wearing light clothes and no
shoes. BMI (kg/m2) was calculated as weight/height2 and
was classified according to European Respiratory Society
(ERS) and American Thoracic Society’s (ATS) recommen-
dation [6]. Mid-upper arm circumference was measured on
the non-dominant arm using a non-stretch tape measure at
the mid point between acromion and olecranon. Waist cir-
cumference (WC) measurement was made around patient’s
bare midriff, at the midpoint between the lowest rib and
the iliac crest, at the end of gentle expiration while standing
without shoes with a non-stretch tape.
Handgrip strength was assessed as a measure of per-
ipheral skeletal muscle strength. A digital handgrip-
dynamometer (Takei TKK-5401) was used to determine
the isometric grasp in each hand by measuring the max-
imally developed strength of the flexors of the fingers. Two
measurements were made in each hand with the arm un-
supported. The mean value of left and right hand strength
was used for statistical analysis.
Body composition was assessed using bioelectrical im-
pedance analysis (BIA) (Bodystat 1500; Bodystat Ltd,
Douglas, UK) with subjects lying supine, with four surface
electrodes placed on the right wrist and ankle. Measure-
ments were obtained in the morning after a fast of at least
3 hours and urination 30 minutes prior to the procedure.
The fat-free mass index (FFMI) (kg/m2) was calculated as
the ratio of FFM to height in meters squared. Fat free mass
index was classified as low FFMI (<16 kg/m2) and normal
FFMI (≥16 kg/m2) [8]. All of the anthropometric measure-
ments were performed by a trained dietitian.
Spirometry and disease severity
Spirometric evaluation of the patients was performed using
a computerized spirometer (Spirolab III SFT) by spirometry
Table 1 General characteristics of COPD patients (n = 65)
Characteristics
Age (y) 62.1 ± 8.9
45-64 38 (58.5)
≥65 27 (41.5)
FEV1 (% of predicted) 50.2 ± 13.6
FVC (%) 64.5 ± 16.6
FEV1/FVC 61.4 ± 7.7
Smoking
Initiation age (y) 14.9 ± 4.4
Pack.years 53.5 ± 28.8
Duration of COPD (y) 6.9 ± 9.2
BMI (kg/m2) 25.3 ± 4.3
FFMI (kg/m2) 18.9 ± 2.6
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ume in the first second (FEV1), forced vital capacity (FVC),
and FEV1/FVC were recorded as percent predicted values.
The FEV1% predicted was measured with the highest value
from at least three technically acceptable spirometric man-
oevres being used. Classification of disease stage was based
on the forced expiratory volume in the first second (FEV1)
value as per GOLD guideline i.e. stage I FEV1 ≥ 80%pre-
dicted, stage II 50% ≤ FEV1 < 80%predicted, stage III 30% ≤
FEV1 < 50%predicted and stage IV < 30% of predicted [1].
Blood parameters
Serum sample from each subject was obtained by a
trained nurse at a fasting state of ≥8 hours and they were
analyzed for visceral protein stores represented by total
protein and serum albumin. The measurements were
performed by the clinical chemistry laboratory of Ankara
Ataturk Chest Diseases and Thoracic Surgery Training
and Research Hospital with the Mannheim/Hitachi 747
analyzer using the bromcresol green method (Roche,
Oxford, CT).
Data analysis
The data were analyzed with SPSS (Statistical Package
for the Social Sciences) WIN 15.0. Descriptive statistics
reported frequencies, percentages, mean (±SD), mini-
mum and maximum values where appropriate as well as
chi-square or Fisher differences. The normality of the
data distribution was tested using visual (histogram and
probability graphics) and analytical methods (Kolmogrov-
Smirnov/Shapiro-Wilk tests). Student’s t test (under
parametric conditions) or Mann–Whitney U test (under
non-parametric conditions) for unpaired data was used for
comparison of general characteristics, nutritional and an-
thropometric data between the low FFMI and normal FFMI
groups. Spearman correlation test examined the relation-
ship between FFMI (kg/m2) and age, spirometry, handgript
strength, total energy expenditure (TEH), physical activity
level (PAL), serum albumin and total protein levels.
Results
General characteristics
The mean age of the patients (n = 65) was 62.1 ± 8.9 years
and most were retired (81.5%) and married (90.8%). The
mean FEV1% predicted was 50.2 ± 13.6%. Duration since di-
agnosed with COPD was significantly lower in moderate
patients than severe patients (5.6 ± 8.7 and 8.2 ± 9.6 years
respectively; p = 0.043). Mean age for starting to smoke was
14.9 ± 4.4 years and the cumulative smoking was 53.5 ±
28.8 pack.years (Table 1). All participants had health insur-
ance and 60% of the patients reported a monthly family
income of less than 700 Turkish Liras (≈US$314). Distribu-
tions of BMI classification of the patients according to
the classification of European Respiratory Society andAmerican Thoracic Society (ERS/ATS) and FFMI are
given in Figure 1. Among all of the patients 13.8% was
underweight, 32.3% was overweight and 15.4% was
obese. On the other hand, low FFMI was assessed in
the 18.5% of the patients. While 11% of the patients
had both low BMI and FFMI, 8% of the patients had a
low FFMI despite a normal BMI (Figure 2). Moderate
and severe COPD patients did not show significant dif-
ference in context of BMI and FFMI distributions when
evaluated separately (data not shown).
Nutritional intake and habitual food consumption
Table 2 lists the participants’ nutritional intake status
assessed by quantitative food frequency questionnaire.
The mean total energy intake was 1906.3 ± 567.4 kcal
and did not show significant difference between low
FFMI and normal FFMI groups (p = 0.478). Seventy five
percent of the patients’ energy intakes were not meeting
the recommended daily intake levels. Although the dif-
ference was not statistically significant, the frequency of
patients whose dietary energy intake did not meet the
RNI levels was higher in the low FFMI group (91.7%).
Daily intakes of carbohydrate, protein, fat and fiber were
273.2 ± 85.7 g, 72.7 ± 25.0 g, 54.1 ± 20.4 g and 20.7 ± 6.5 g
respectively. Mean fiber intake was 20.7 ± 6.5 g and 90.8%
of the patients could not meet RNI for fiber. Neither vita-
min nor mineral intakes were different between the two
FFMI groups. The mean percentages of meeting the daily
recommended intakes (RNI) were lowest for magnesium
(57.0 ± 21.3%) and calcium (62.2 ± 29.1%). None of the pa-
tients with low FFMI could meet the RNI levels for fiber,
magnesium, calcium and zinc.
Habitual daily food consumption of COPD patients
assessed by quantitative food frequency questionnaire is
given in Table 3. Mean daily consumption of dairy prod-
ucts was 220.1 ± 170.4 g and 95.4% of the patients’ dairy
consumption was below the recommended levels. Mean
Figure 1 BMI and FFMI distributions of COPD patients (n = 65). a. Values indicating the patients with BMI values <21 kg/m2 (underweight),
between 21-24.99 kg/m2 (normal weight), between 25-29.99 kg/m2 (overweight) and ≥30 kg/m2 (obese) are shown as percentages (%). b. Values
indicating the patients with FFMI values <16 kg/m2 (low FFMI) and ≥16 kg/m2 (normal FFMI) are shown as percentages (%). Abbreviations: BMI:
Body mass index; FFMI: Fat-free mass index.
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5.6 g/day and nearly 97% was not meeting the RNI for le-
gumes. Mean daily fruit and vegetable consumption was
389.9 ± 200.1 g and 92.3% of the patients’ consumption was
below the RNI for fruits and vegetables. Mean daily con-
sumptions of milk-yogurt, red meat and fruits were found
to be significantly low in the low FFMI group compared to
normal FFMI group (for all; p < 0.05).
Anthropometric measurements, body composition,
physical activity level and blood parameters
Anthropometric measurements, handgrip strength, total
energy expenditure (TEE), physical activity level (PAL) and
some blood parameters of COPD patients are given in
Table 4. Patients with normal FFMI had significantly higher
weight, height, WC, MUAC, fat and fat-free mass than the
patients with low FFMI. Mean handgript strength of the
low FFMI group was 26.1 ± 4.7 kg while it was 34.6 ± 7.9
kg in the normal FFMI group (p = 0.001). Total energy ex-
penditure (TEE) assessed by 24-h recall was also signifi-
cantly low in the low FFMI group, but the physical activity





Normal BMI normal FFMI
Normal BMI low FFMI
Low BMI normal FFMI
Low BMI low FFMI
Figure 2 The prevalence of different depletion categories. Blue:
normal BMI and FFMI; red: normal BMI and FFM depletion; green:
low BMI and normal FFM; purple: low BMI and FFMI.correlation between FFMI and handgript strength (r =
0.331, p = 0.007) and a positive moderate correlation be-
tween FFMI and TEE (r = 0.548, p = 0.000) (Table 5).
Hemoglobin and hemotoctrit levels were significantly lower
in the low FFMI group (for all; p < 0.05) (Table 4). A posi-
tive weak correlation was found between FFMI and serum
albumin (r = 0.288, p = 0.022) (Table 5).
Discussion
General characteristics
The present study which included male COPD patients
with moderate to severe airway obstruction showed that
dietary intake and habitual food consumption differ in
relation to fat-free mass index. The link between aging
and the pathogenesis of COPD is strongly supported
[10] and longer duration of the disease since diagnose in
severe COPD patients in our study can be explained by
the progressive nature of the disease [1]. Cigarette smok-
ing is the most important environmental risk factor for
the development of COPD [13]. In our study the mean
age for starting to smoke corresponded to adolescence,
similar to the findings of a recent study by Kim et al.
[14], who found the mean initiation age of smoking of
COPD patients as 16.4 ± 4.8 years.
In the current study 18.5% of patients were character-
ized by a low FFMI. Similarly, a study among 72 COPD
outpatients suffering from a moderate degree of airflow
obstruction showed that prevalance of fat-free mass de-
pletion was 18% in male patients [15]. In another study,
among moderate to severe COPD patients the preva-
lance of fat free mass depletion was 20.3% in male pa-
tients [16]. A recent study by Van de Bool et al. [11]
showed that almost 25% of moderate to severe COPD
patients who were eligible for pulmonary rehabilitation
were characterized by a low FFMI. These little discrep-
ancies may be explained by different inclusion criteria of
the studies. On the other hand, in a cross-sectional study
among male COPD patients, depletion of fat-free mass
Table 2 Energy and nutrient intakes of COPD patients assessed by food frequency questionnaire
Low FFMI (n = 12) Normal FFMI (n = 53) Total (n = 65)
X ± SD X ± SD p X ± SD
Energy (kcal) 1770.0 ± 338.2 1937.2 ± 605.7 0.478 1906.3 ± 567.4
RNI (%) 81.3 ± 15.1 86.1 ± 24.4 0.519 85.2 ± 22.9
<RNI 11 (91.7) 38 (71.7) 0.266 49 (75.4)
Carbohydrate (g) 258.4 ± 46.9 276.6 ± 92.3 0.488 273.2 ± 85.7
Protein (g) 68.4 ± 15.4 73.7 ± 26.7 0.946 72.7 ± 25.0
Fat (g) 48.1 ± 13.6 55.5 ± 21.5 0.398 54.1 ± 20.4
Ratio of C:P:F 60:16:24 58:16:26 - 58:16:26
Fiber (g) 19.3 ± 3.8 21.0 ± 6.9 0.499 20.7 ± 6.5
RNI (%) 66.4 ± 13.2 72.3 ± 23.9 0.254 71.2 ± 22.3
<RNI 12 (100.0) 47 (88.7) 0.583 59 (90.8)
Vitamin A (mcg) 1029.2 ± 1365.4 782.2 ± 621.6 0.710 827.8 ± 802.3
RNI (%) 114.4 ± 151.2 86.9 ± 69.1 0.340 92.0 ± 89.1
<RNI 8 (66.7) 41 (77.4) 0.470 49 (75.4)
Vitamin E (mg) 16.3 ± 5.1 17.3 ± 7.0 0.710 17.1 ± 6.6
RNI (%) 108.5 ± 33.7 115.6 ± 46.5 0.618 114.3 ± 44.3
<RNI 4 (33.3) 20 (37.7) 1.000 24 (36.9)
Vitamin B12 (mcg) 4.9 ± 4.8 3.8 ± 3.0 0.442 4.0 ± 3.4
RNI (%) 202.1 ± 201.1 160.0 ± 123.3 0.350 167.7 ± 139.9
<RNI 3 (25.0) 21 (39.6) 0.511 24 (39.6)
Vitamin C (mg) 115.2 ± 34.7 115.6 ± 60.3 0.389 115.5 ± 56.2
RNI (%) 128.0 ± 38.6 128.5 ± 67.0 0.979 128.4 ± 62.4
<RNI 1 (8.3) 20 (37.7) 0.084 21 (32.3)
Calcium (mg) 654.0 ± 141.7 759.8 ± 334.8 0.302 740.2 ± 310.2
RNI (%) 54.5 ± 11.8 65.2 ± 31.4 0.057 63.2 ± 29.1
<RNI 12 (100.0) 48 (90.6) 0.575 60 (92.3)
Iron (mg) 9.1 ± 1.9 9.9 ± 3.3 0.594 9.8 ± 3.1
RNI (%) 91.2 ± 19.2 99.2 ± 33.1 0.423 97.7 ± 31.0
<RNI 7 (58.3) 30 (56.6) 0.913 37 (56.9)
Zinc (mg) 8.1 ± 1.7 9.0 ± 3.2 0.660 8.8 ± 3.0
RNI (%) 74.0 ± 15.8 81.8 ± 29.2 0.375 80.3 ± 27.3
<RNI 12 (100.0) 42 (79.2) 0.109 54 (83.1)
Magnesium (mg) 205.3 ± 53.8 247.0 ± 94.2 0.217 239.3 ± 89.3
RNI (%) 48.9 ± 12.8 58.8 ± 22.4 0.145 57.0 ± 21.3
<RNI 12 (100.0) 49 (92.5) 1.000 61 (93.8)
Energy and nutrient intakes of COPD patients assessed by food frequency questionnaire. Values for actual nutrient intakes and percentage of meeting the RNI
levels are shown as mean ± SD. Values indicating the number of patients with nutrient intakes below RNI (<RNI) are shown as number and percentage (%) in
parenthesis. None of the differences between the low FFMI group and the normal FFMI group were significant. RNI: recommended nutrient intake.
Yılmaz et al. Nutrition Journal  (2015) 14:35 Page 5 of 10based on fat-free mass index was about 42% [17]. This
discrepancy can be due to more severe COPD being
present in the study as they mentioned that the preva-
lance of low FFMI was high among severe to very severe
(stage IV) COPD patients.
Increased BMI does not protect against fat-free mass
depletion in COPD, since there is a preferential loss of
muscle tissue in this disease [18]. In our study 8% of thepatients had low FFMI despite a BMI ≥21 kg/m2. A study
by Pirabbasi et al. [17] showed that among 271 male COPD
patients 11.1% had a low FFMI (<16 kg/m2) despite a nor-
mal BMI (≥21 kg/m2). In the study by Vermeeren et al.
[16], the prevalence of being underweight was 17% whereas
prevalence of FFM depletion was 42%. It should be noted
however that in their study they used <18.5 kg/m2 as the
BMI cutoff for being underweight.
Table 3 Daily food consumption of COPD patients assessed by quantitative food frequency questionnaire (n = 65)
Low FFMI (n = 12) Normal FFMI (n = 53) Total (n = 65)
Food groups (g/day) X ± SD X ± SD p X ± SD
Dairy products 117.9 ± 86.6 243.3 ± 176.7 0.007* 220.1 ± 170.4
<RNI 12 (100.0) 50 (94.3) 1.000 62 (95.4)
Milk-yogurt 85.4 ± 86.4 208.1 ± 174.0 0.004* 185.5 ± 167.9
<RNI 12 (100.0) 51 (96.2) 1.000 63 (96.9)
Cheese 32.5 ± 19.9 35.2 ± 22.9 0.986 34.7 ± 22.2
<RNI 3 (25.0) 17 (85.0) 0.741 20 (30.8)
Meats, eggs, legumes, nuts 110.7 ± 43.8 123.2 ± 62.1 0.800 120.9 ± 59.0
<RNI 9 (75.0) 36 (67.9) 0.673 55 (84.6)
Red meat 4.8 ± 6.5 12.7 ± 14.3 0.044* 11.2 ± 13.5
Chicken, turkey 33.6 ± 31.6 44.7 ± 34.2 0.260 42.7 ± 33.8
Fish 23.0 ± 26.9 28.9 ± 27.1 0.450 27.8 ± 26.9
Eggs 27.1 ± 14.2 20.7 ± 17.6 0.116 21.9 ± 17.1
<RNI 0 (0.0) 8 (15.1) 0.333 8 (12.3)
Legumes 8.2 ± 4.8 9.1 ± 5.8 0.428 8.9 ± 5.6
<RNI 12 (100.0) 51 (96.2) 1.000 63 (96.9)
Nuts 14.1 ± 15.5 7.2 ± 11.1 0.531 8.5 ± 12.2
Bread-grains 310.9 ± 112.3 343.4 ± 140.1 0.434 337.3 ± 135.1
<RNI 10 (83.3) 40 (75.5) 0.717 38 (58.5)
Fruits 124.0 ± 109.3 222.3 ± 121.8 0.013* 204.1 ± 124.8
Vegetables 167.5 ± 104.1 190.0 ± 129.0 0.576 185.8 ± 124.3
Fruits and vegetables 150.3 ± 43.4 412.2 ± 204.4 0.058 389.9 ± 200.1
<RNI 12 (100.0) 48 (90.6) 0.575 60 (92.3)
Oils-fats 30.3 ± 20.2 26.8 ± 11.2 0.906 27.4 ± 13.2
<RNI 8 (66.7) 42 (79.2) 0.449 50 (76.9)
Sugar 41.6 ± 30.5 42.5 ± 36.5 0.946 42.3 ± 35.3
<RNI 10 (83.3) 36 (67.9) 0.484 50 (76.9)
Daily food consumption of COPD patients assessed by quantitative food frequency questionnaire (n = 65). Values for actual intakes are shown as mean ± SD.
Values indicating the number of patients with food consumption below RNI (<RNI) are shown as number and percentage (%) in parenthesis. Asterisks indicate a
significant difference between groups: *P < 0.05. Daily dairy, milk-yogurt, red meat and fruit consumptions of patients with low FFMI were significantly lower.
RNI: recommended nutrient intake.
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In the current study, mean daily energy intakes of COPD
patients was 1906 kcal similarly to a group of 275 moderate
to severe COPD patients (93% male) in Spain, whose mean
daily energy intake was 2033 kcal [19]. According to Turkey
Health and Nutrition Survey-2010, mean energy intake of
Turkish individuals was 1918 kcal in the 51–64 years age
group and 1706 kcal in the 65–74 year age group [20]. A
study in Malaysia with 149 COPD patients showed that
dietary energy intake of patients (assessed by one day or
two days record) was below Malaysian RNI [18]. Compared
to the Malaysian sample, in our study prevalance of patients
with energy intake below RNI is lower yet clinically signifi-
cant (93% vs 75%, respectively). A recent study by Van de
Bool et al., which is the only study to evaluate dietary intake
of COPD patients in relation to body composition untilnow, showed that COPD patients with low FFMI reported
higher energy intake than patients with normal FFMI [11].
On the contrary, in the current study mean energy intake
of patients in the low FFMI group was lower than normal
FFMI group (1770 ± 338 and 1937 ± 606 kcal, respectively).
Selective wasting of fat-free mass is suggesting a dis-
turbed protein balance in COPD patients [21]; hence, pro-
tein intake of depleted COPD patients is recommended to
exceed 1.5 g/kg/day [22]. Increased protein intake and
physical activity, in the form of resistance training, stimu-
late muscle protein synthesis in the elderly [23]. In the
study of Van de Bool et al. [11], COPD pateints with low
FFMI reported significantly higher protein intake per kg
body weight. In the current study, protein intake of patients
did not differ between low and normal FFMI groups. How-
ever, daily consumptions of dairy products and red meat
Table 4 Body composition, handgrip strength, physical activity level (PAL) and some blood parameters of COPD patients
Low FFMI (n = 12) Normal FFMI (n = 53) Total (n = 65)
Characteristics X ± SD X ± SD p X ± SD
Weight (kg) 55.1 ± 6.4 75.4 ± 10.9 0.000** 71.6 ± 12.9
Height (cm) 164.1 ± 5.9 168.8 ± 5.9 0.015* 167.9 ± 6.1
WC (cm) 83.9 ± 7.6 101.0 ± 11.4 0.000** 97.8 ± 12.6
MUAC (cm) 25.1 ± 1.7 30.2 ± 3.0 0.000** 29.3 ± 3.4
FM (g) 14.8 ± 3.4 18.8 ± 6.4 0.042* 18.1 ± 6.1
FM (%) 26.7 ± 3.6 24.5 ± 5.5 0.155 24.9 ± 5.2
FFM (g) 40.3 ± 4.0 56.3 ± 6.3 0.000** 53.4 ± 8.6
FFM (%) 73.3 ± 3.6 75.5 ± 5.5 0.146 75.1 ± 5.2
Handgript strength (kg) 26.1 ± 4.7 34.6 ± 7.9 0.001* 33.1 ± 8.1
TEE (kkal/d) 2031.9 ± 344.3 2463.5 ± 426.6 0.002* 2382.8 ± 443.5
PAL 1.5 ± 0.2 1.6 ± 0.2 0.156 1.5 ± 0.2
WBC 8.3 ± 2.2 8.4 ± 1.8 0.882 8.4 ± 1.9
HG (g/dL) 14.5 ± 1.5 15.4 ± 1.3 0.038* 15.3 ± 1.4
HCT (%) 43.4 ± 4.3 46.3 ± 3.8 0.024* 45.7 ± 4.0
Serum albumin (g/dL) 4.1 ± 0.4 4.3 ± 0.3 0.051 4.2 ± 0.3
Serum total protein (g/dL) 6.8 ± 0.4 7.0 ± 0.5 0.289 7.0 ± 0.5
Body composition, handgrip strength, physical activity level (PAL) and some blood parameters of COPD patients. Values are shown as mean ± SD. Asterisks
indicate a significant difference between groups: *P < 0.05; **P < 0.001. Patients with low FFMI had significantly lower weight, height, WC, MUAC, FM, FFM,
handgrip strength, TEE, HG and HCT values. Abbreviations: WC waist circumference, MUAC mid-upper arm circumference, FM fat mass, FFM fat-free mass, TEE total
energy expenditure, PAL physical activity level, WBC white blood cells, HG hemglobin, HCT hematoctrit.
Yılmaz et al. Nutrition Journal  (2015) 14:35 Page 7 of 10were significantly low in the low FFMI group. This finding
is considerable since high-quality protein sources such as
whey protein, milk, and beef have been shown to improve
protein synthetic response in the elderly [24].
In the current study, majority of patients’ daily milk
and yogurt consumption was below RNI and this finding
was more marked in the patients with low FFMI. Milk
proteins (casein and whey) are known for their high
branched-chain amino acid (BCAA) content, which in-
clude leucine (LEU), isoleucine (ILE) and valine (VAL)Table 5 Spearman’s rank correlation between FFMI




FEV1 (%) 0.092 0.465
FEV1/FVC (%) 0.217 0.082
Handgript strength (kg) 0.331 0.007*
TEE (kkal/d) 0.548 0.000**
PAL 0.216 0.084
Serum albumin (g/dL) 0.288 0.022*
Serum total protein (g/dL) 0.159 0.213
Spearman’s rank correlation between FFMI (kg/m2) and some parameters.
Asterisks indicate a significant correlation between groups:
*P < 0.05; **P < 0.001.[25]. Since skeletal muscle is a major site of (BCAA) catab-
olism in disease state, they are used for maintenance of pro-
tein quality and repair process of tissues [26]. Plasma levels
of BCAAs, particularly leucine, are reduced in patients with
COPD [27] and a significant association was found between
low levels of BCAAs and depletion of FFM [17]. Engelen
et al. showed an elevated anabolic response to sip feeding
of a casein protein meal in patients with COPD [28]. All of
these findings make milk proteins an important preventive
approach to conserve muscle mass in COPD.
In this study, a vast majority (92%) of the COPD patients
could not meet RNI for fruits and vegetables with mean
daily consumption of fruits being significantly lower in the
low FFMI group compared to normal FFMI group. This
finding is concerning since cross-sectional studies have
showed a significant positive association between fruit and
vegetable (FV) intake and forced expiratory volume in 1 s
(FEV1), with stronger evidence for fruit consumption
[29,30]. Data from the MORGEN study showed that higher
intakes of antioxidants such as vitamin C, beta-carotene
and flavonoids are associated with higher FEV1 values,
compared with low intakes [31,32]. Moreover, Walda et al.
[33] demonstrated an inverse association between fruit in-
take and 20 yr COPD mortality.
The major deficiencies were assessed in magnesium
and calcium intakes in the current study. Mean magne-
sium intake of COPD patients was 239.3 ± 89.3 mg in
Yılmaz et al. Nutrition Journal  (2015) 14:35 Page 8 of 10our study. According to National Turkish Health and Nu-
trition Survey (NTHNS) 2010, mean magnesium intake
was 290.8 mg in the 51–64 year old group, 271.3 mg in the
65–74 year old group and 241.7 mg in 75 years and older
[20]. Mean magnesium intake of COPD patients in our
study was lower than all of the age groups in the national
survey. Low consumption of dark leafy vegetables, nuts and
seeds due to chewing problems [34], or legumes due to
gastrointestinal disturbances [35] might be the reason of
low magnesium intake in our group of COPD patients.
Mean calcium intake in the current study was 740.2 ±
310.2 mg and 92% of the patients’ intake could not meet
RNI. Calcium intake in the NTHNS-2010 was 712.7 mg
in the 51–64 year olds, 677.2 mg in the 65–74 year olds
and 592.6 mg in 75 years and older [20]. In the study by
Van de Bool et al. which evaluated the dietary intake of
COPD patients assessed by using a cross-check dietary
history in in Netherlands, calcium intake was reported
as “too low” since 72% of the patients’ dietary intake
could not meet the RNI [11]. In the COPD patients in
this study, the reported percentage of patients with cal-
cium intake below recommendations was remarkably
higher. In a Spanish group of 275 moderate to severe
COPD patients, prevalence of complience with recom-
mendations was 31% for magnesium and 49% for cal-
cium and similar to our study magnesium was the major
mineral deficieny [19].
We did not find any significant differences in daily
macro- and micronutrient intakes between patients with
low FFMI and normal FFMI. Unlikely to our study, Van
de Bool et al. recently showed that intakes of calcium
and vitamin A in COPD patients with low FFMI were
significantly higher [11]. The consumption of legumes,
dairy products, fruits and vegetables were lowest as ma-
jority of the patients’ intakes did not comply with the
recommendations in our sample. In a Spanish group of 275
moderate to severe COPD patients daily legume consump-
tion was 31 ± 21 g while in our study it is 8.9 ± 5.6 g. This
difference may be attributed to cultural differences between
the countries.
Anthropometric measurements, body composition and
physical activity level
In the present study mean weight, height, waist circum-
ference (WC), mid-upper arm circumference (MUAC),
fat mass and fat-free mass were significantly lower in pa-
tients with low FFMI. Mid-upper arm circumference cor-
relate with total muscle mass and is therefore used to
predict changes in the protein nutritional status [36]. Ac-
cordingly, in the present study mean MUAC of patients
with low FFMI was significantly low.
Patients with COPD have a significantly reduced dur-
ation, intensity, and counts of daily physical activity when
compared to healthy control subjects [37]. Low fat-freemass has been shown to impair exercise performance in
COPD patients [38]. A recent study by Andersson et al.
[39] showed that COPD patients who were more physically
active were characterized not only by better pulmonary
function but also higher BMI and FFMI. In the current
study, mean total daily energy expenditure of patients with
low FFMI was significantly low. Additionally, mean physical
activity levels was lower in the low FFMI group, but the dif-
ference was not statistically significant.
Serum albumin is synthesized in the liver and is a marker
of nutritional status. Data suggest that low serum albumin
is associated with low appendicular skeletal muscle mass in
elderly women and men. Reduced protein metabolism with
aging may occur concurrently in the liver and muscle
causing similar decrements in both serum albumin and
muscle mass [40]. Although in our study mean serum
albumin levels were not markedly different between
low and normal FFMI groups, there was a positive weak
correlation between FFMI and serum albumin.
Cesari et al. showed in their study that hemoglobin
levels were associated with muscle and fat mass changes,
and that decreased muscular strength occured in the
presence of anemia in individuals who were 65 years and
older [41]. Similarly to these findings, in our study pa-
tients with low FFMI had significantly low hemoglobin and
hematocrit levels.Limitations
Some shortcomings of the current study need to be consid-
ered. First, no healthy control group could be included in
the present analyses in order to compare the nutritional
intake between COPD patients and healthy subjects.
Nevertheless, results were compared with general find-
ings in general older Turkish adults from the Natonal
Turkish Nutrition and Health Survey-2010 [20]. Second,
loss of FFM seems to be more frequent in patients with
emphysema-type COPD than in patients with chronic
bronchitis. Unfortunately, we were unable to differentiate
COPD subtypes in our study. Third, the assessment of diet-
ary intake of fat might be underestimated in food frequency
questionnaire. The food frequency method is generally ap-
plied in order to assess the quality of dietary intake because
it is able to provide data about particular food groups.
While there is concern that food frequency questionnaires
can be prone to measurement error [42], they have been
shown to identify similar patterns of diet as other dietary
methods [43].
Fourth, in the current study physical activity was assessed
by a 24-h recall questionnaire. It has been reported that
COPD patients overestimate the time spent walking and
underestimate time spent standing. Therefore, using a mul-
tisensor armband or an accelerometer to assess physical ac-
tivity would be more reliable [37].
Yılmaz et al. Nutrition Journal  (2015) 14:35 Page 9 of 10Conclusions
Health proffesionals, especially dietitians should be aware
of COPD patients with low FFMI in order to evaluate the
nutritional intake and therefore plan nutritional strategies
to improve prognosis of the disease. Dietary strategies to
prevent fat-free mass loss in COPD patient should be fur-
ther investigated.
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